88 related articles for article (PubMed ID: 16419642)
1. A novel missense mutation, F826Y, in the mineralocorticoid receptor gene in Japanese hypertensives: its implications for clinical phenotypes.
Kamide K; Yang J; Kokubo Y; Takiuchi S; Miwa Y; Horio T; Tanaka C; Banno M; Nagura J; Okayama A; Tomoike H; Kawano Y; Miyata T
Hypertens Res; 2005 Sep; 28(9):703-9. PubMed ID: 16419642
[TBL] [Abstract][Full Text] [Related]
2. Three novel missense mutations of WNK4, a kinase mutated in inherited hypertension, in Japanese hypertensives: implication of clinical phenotypes.
Kamide K; Takiuchi S; Tanaka C; Miwa Y; Yoshii M; Horio T; Mannami T; Kokubo Y; Tomoike H; Kawano Y; Miyata T
Am J Hypertens; 2004 May; 17(5 Pt 1):446-9. PubMed ID: 15110905
[TBL] [Abstract][Full Text] [Related]
3. [Genetic disorders caused by gain or loss of function of the mineralocorticoid receptor].
Arai K; Shibasaki T
Nihon Rinsho; 2002 Feb; 60(2):361-6. PubMed ID: 11857927
[TBL] [Abstract][Full Text] [Related]
4. Crystal structure of a mutant mineralocorticoid receptor responsible for hypertension.
Fagart J; Huyet J; Pinon GM; Rochel M; Mayer C; Rafestin-Oblin ME
Nat Struct Mol Biol; 2005 Jun; 12(6):554-5. PubMed ID: 15908963
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the S810L point mutation of the mineralocorticoid receptor in patients with pregnancy-induced hypertension.
Schmider-Ross A; Wirsing M; Büscher U; Neitzel H; Krause M; Henrich W; Reles A; Dudenhausen JW
Hypertens Pregnancy; 2004; 23(1):113-9. PubMed ID: 15117605
[TBL] [Abstract][Full Text] [Related]
6. Identification of steroid ligands able to inactivate the mineralocorticoid receptor harboring the S810L mutation responsible for a severe form of hypertension.
Pinon GM; Fagart J; Souque A; Auzou G; Vandewalle A; Rafestin-Oblin ME
Mol Cell Endocrinol; 2004 Mar; 217(1-2):181-8. PubMed ID: 15134816
[TBL] [Abstract][Full Text] [Related]
7. Structural basis of spirolactone recognition by the mineralocorticoid receptor.
Huyet J; Pinon GM; Fay MR; Fagart J; Rafestin-Oblin ME
Mol Pharmacol; 2007 Sep; 72(3):563-71. PubMed ID: 17569793
[TBL] [Abstract][Full Text] [Related]
8. Relationship of aldosterone synthase gene (C-344T) and mineralocorticoid receptor (S810L) polymorphisms with gestational hypertension.
Ramírez-Salazar M; Romero-Gutiérrez G; Zaina S; Malacara JM; Kornhauser C; Pérez-Luque E
J Hum Hypertens; 2011 May; 25(5):320-6. PubMed ID: 20535141
[TBL] [Abstract][Full Text] [Related]
9. Mineralocorticoid receptor mutations are the principal cause of renal type 1 pseudohypoaldosteronism.
Pujo L; Fagart J; Gary F; Papadimitriou DT; Claës A; Jeunemaître X; Zennaro MC
Hum Mutat; 2007 Jan; 28(1):33-40. PubMed ID: 16972228
[TBL] [Abstract][Full Text] [Related]
10. Genetic variations of HSD11B2 in hypertensive patients and in the general population, six rare missense/frameshift mutations.
Kamide K; Kokubo Y; Hanada H; Nagura J; Yang J; Takiuchi S; Tanaka C; Banno M; Miwa Y; Yoshii M; Matayoshi T; Yasuda H; Horio T; Okayama A; Tomoike H; Kawano Y; Miyata T
Hypertens Res; 2006 Apr; 29(4):243-52. PubMed ID: 16778331
[TBL] [Abstract][Full Text] [Related]
11. The severe form of hypertension caused by the activating S810L mutation in the mineralocorticoid receptor is cortisone related.
Rafestin-Oblin ME; Souque A; Bocchi B; Pinon G; Fagart J; Vandewalle A
Endocrinology; 2003 Feb; 144(2):528-33. PubMed ID: 12538613
[TBL] [Abstract][Full Text] [Related]
12. Elucidating the underlying molecular pathogenesis of NR3C2 mutants causing autosomal dominant pseudohypoaldosteronism type 1.
Riepe FG; Finkeldei J; de Sanctis L; Einaudi S; Testa A; Karges B; Peter M; Viemann M; Grötzinger J; Sippell WG; Fejes-Toth G; Krone N
J Clin Endocrinol Metab; 2006 Nov; 91(11):4552-61. PubMed ID: 16954160
[TBL] [Abstract][Full Text] [Related]
13. Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy.
Geller DS; Farhi A; Pinkerton N; Fradley M; Moritz M; Spitzer A; Meinke G; Tsai FT; Sigler PB; Lifton RP
Science; 2000 Jul; 289(5476):119-23. PubMed ID: 10884226
[TBL] [Abstract][Full Text] [Related]
14. Epidermolysis bullosa simplex in Japanese and Korean patients: genetic studies in 19 cases.
Yasukawa K; Sawamura D; Goto M; Nakamura H; Jung SY; Kim SC; Shimizu H
Br J Dermatol; 2006 Aug; 155(2):313-7. PubMed ID: 16882168
[TBL] [Abstract][Full Text] [Related]
15. Alport syndrome. Molecular genetic aspects.
Hertz JM
Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
[TBL] [Abstract][Full Text] [Related]
16. The molecular basis of hypertension.
Toka HR
Turk J Pediatr; 2002; 44(3):183-93. PubMed ID: 12405428
[TBL] [Abstract][Full Text] [Related]
17. Genotyping of resistance to thyroid hormone in South American population. Identification of seven novel missense mutations in the human thyroid hormone receptor beta gene.
Rivolta CM; Olcese MC; Belforte FS; Chiesa A; Gruñeiro-Papendieck L; Iorcansky S; Herzovich V; Cassorla F; Gauna A; Gonzalez-Sarmiento R; Targovnik HM
Mol Cell Probes; 2009; 23(3-4):148-53. PubMed ID: 19268523
[TBL] [Abstract][Full Text] [Related]
18. Association of a mineralocorticoid receptor gene polymorphism with hypertension in a Spanish population.
Martinez F; Mansego ML; Escudero JC; Redon J; Chaves FJ
Am J Hypertens; 2009 Jun; 22(6):649-55. PubMed ID: 19325532
[TBL] [Abstract][Full Text] [Related]
19. Analysis of ankyrin-B gene mutations in patients with long QT syndrome.
Zhou X; Shimizu M; Konno T; Ino H; Fujino N; Uchiyama K; Mabuchi T; Kaneda T; Fujita T; Masuda E; Kato H; Funada A; Mabuchi H
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jul; 26(7):901-3, 909. PubMed ID: 16864073
[TBL] [Abstract][Full Text] [Related]
20. The RGS2 gene product from a candidate hypertension allele shows decreased plasma membrane association and inhibition of Gq.
Gu S; Tirgari S; Heximer SP
Mol Pharmacol; 2008 Apr; 73(4):1037-43. PubMed ID: 18230714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
